Page last updated: 2024-11-03

proglumetacin and Cholera Infantum

proglumetacin has been researched along with Cholera Infantum in 2 studies

proglumetacin : A carboxylic ester obtained by formal condensation of the carboxy group of indometacin with the hydroxy group of 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl N(2)-benzoyl-N,N-dipropyl-alpha-glutaminate. Used (as its dimaleate salt) to control pain and inflammation associated with musculoskeletal and joint disorders. Following oral administration, it is metabolised to indometacin and proglumide, a drug with antisecretory effects that helps prevent injury to the stomach lining.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manero Guardiola, F1
Chillon, F1
Rodriguez de Guzman, F1
Arias Vallejo, E1
Yanagawa, A1
Fukumura, T1
Matsui, H1
Uemura, H1
Endo, T1
Nakagawa, T1
Mizushima, Y1

Trials

1 trial available for proglumetacin and Cholera Infantum

ArticleYear
Possible mechanisms of gastroduodenal mucosal damage in volunteers treated with nonsteroidal antiinflammatory drugs--the usefulness of prodrugs.
    The Journal of rheumatology, 1992, Volume: 19, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Digestive System; Dinoprostone; Double-B

1992

Other Studies

1 other study available for proglumetacin and Cholera Infantum

ArticleYear
Open evaluation of the efficacy and endoscopic gastric tolerance of proglumetacin in chronic rheumatic in-patients.
    Current medical research and opinion, 1982, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Drug Evaluation; Drug Tole

1982